Magno Humphries Laboratories, Inc. has recalled 2,400 bottles of Senna Laxative (sennosides) tablets, 8.6 mg, because the bottles may actually contain Naproxen Sodium 220 mg tablets instead of the intended laxative. This recall was initiated after a customer complaint confirmed that a bottle labeled as Senna Laxative contained only the pain reliever/fever reducer Naproxen. Taking Naproxen Sodium when intending to take a laxative can lead to unintentional medication errors and potential adverse health effects. These 100-count bottles were manufactured for Basic Drugs, Inc. and distributed nationwide.
A label mix-up means consumers may unknowingly ingest Naproxen Sodium, a nonsteroidal anti-inflammatory drug (NSAID), which can cause serious side effects such as gastrointestinal bleeding or allergic reactions, especially in individuals with contraindications to NSAIDs.
Healthcare consultation and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.